A recent launch by Abbot shows the usefulness of Poly(lactide) (such as that sold at www.polyscitech.com) which can be used to make a fully resorbable drug eluting stent.
"Absorb drug-eluting bioresorbable vascular scaffold is safer and more effective than metallic stents, and the company has begun shipping the device in Europe and parts of the Asia-Pacific region and Latin America. The first-of-its-kind tech works much like a common vascular stent at first, restoring blood flow to a clogged vessel and administering the drug everolimus. However, Absorb is made of polylactide, a common material in dissolving sutures, allowing it be resorbed by the body over time, leaving behind a treated vessel free to move, flex, pulsate and dilate, Abbott says.
The commercial launch abroad follows 5 studies in more than 20 countries in which Absorb was found to perform just as well as best-in-class drug-eluting stents, Abbott says. "We are proud to be the first company to commercialize a drug eluting bioresorbable vascular scaffold, which has the potential to revolutionize the way physicians treat their patients with coronary artery disease," John Capek, Abbott's executive VP for devices, said in a statement."
Read more: Abbott launches dissolving stent abroad - FierceMedicalDevices http://www.fiercemedicaldevices.com/story/abbott-launches-dissolving-stent-abroad/2012-09-25#ixzz27bvalN1b
Also more at
http://abbott.com/news-media/press-releases/abbott-announces-international-launch-of-the-absorb-bioresorbable-vascular-scaffold.htm
No comments:
Post a Comment